In summary, the current study demonstrates a novel role for WA in both preventing and therapeutically alleviating GalN/LPS-induced FH via targeting the macrophage that is partially dependent on NLRP3 (Fig. 7d). This evidence concerns the gene NLRP3 and familial hyperaldosteronism.